4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinoma.
Saved in:
| Title: | 4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinoma. |
|---|---|
| Authors: | Vasudev NS; Department of Medical Oncology, St James's University Hospital, Leeds, UK. n.vasudev@leeds.ac.uk., Aleem U; Department of Medical Oncology, Christie Hospital, Manchester, UK., Humphries K; Department of Medical Oncology, St James's University Hospital, Leeds, UK., Pillai M; Department of Medical Oncology, Christie Hospital, Manchester, UK., Pickwell-Smith B; Department of Medical Oncology, St James's University Hospital, Leeds, UK., Ralph C; Department of Medical Oncology, St James's University Hospital, Leeds, UK., Jagdev S; Department of Medical Oncology, St James's University Hospital, Leeds, UK., Simpson J; Department of Medical Oncology, St James's University Hospital, Leeds, UK., Dearden H; Department of Medical Oncology, St James's University Hospital, Leeds, UK., Waddell T; Department of Medical Oncology, Christie Hospital, Manchester, UK. |
| Source: | BJC reports [BJC Rep] 2026 May 08; Vol. 4 (1). Date of Electronic Publication: 2026 May 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918752188106676 Publication Model: Electronic Cited Medium: Internet ISSN: 2731-9377 (Electronic) Linking ISSN: 27319377 NLM ISO Abbreviation: BJC Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2731-9377 |
|---|---|
| DOI: | 10.1038/s44276-026-00224-y |
